Filing Details
- Accession Number:
- 0001144204-18-053713
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-12 21:50:16
- Reporting Period:
- 2018-10-12
- Accepted Time:
- 2018-10-12 21:50:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1540159 | Stellar Biotechnologies Inc. | SBOT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621331 | E. Daniel Morse | C/O Stellar Biotechnologies, Inc. 332 East Scott Street Port Hueneme CA 93041 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, Without Par Value | Disposition | 2018-10-12 | 7,047 | $1.31 | 20,741 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share.
Billionaire Hedge Funds
